Business
This company has entered a trading halt, is it about to announce FDA approval?
Image source: Getty Images
Orthocell Ltd (ASX: OCC) is an Australian medical technology company focused on developing and commercialising innovative regenerative medicine treatments.
Over the last 12 months its share price has skyrocketed, up more than 260% in that span.
For context, S&P/ASX…
Continue Reading
-
General19 hours agoTwo people arrested after man fatally shot at McLaren Flat
-
General10 hours agoICAC investigating University of Wollongong as chancellor grilled at Inquiry
-
General17 hours agoWarner Bros Discovery board rejects rival $163bn bid from Paramount
-
General23 hours agoMan refused bail charged with depicting Adolf Hitler and Nazi symbols on boat